Skip to main content
Livermore
Livermore
ZHEN

Whitefort Capital Management, LP

SEC CIK
0001884931
Latest filing
Aug 14, 2026

The latest 13F from Whitefort Capital Management, LP covers Q2 2026 (filed Aug 14, 2026): 19 long positions worth $405.7M. The top 10 holdings make up 78.5% of the portfolio, and the largest is Arbutus Biopharma Corp (ABUS) at 18.7%. Livermore has 20 filings on Form 13F from this institution, going back to Q4 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
2
Est. +$28.2M
Added
6
Est. +$44.9M
Reduced
4
Est. −$33.7M
Sold out
2
Est. −$11.1M

Top 5 holdings

Share of this quarter's portfolio value

  1. ABUSArbutus Biopharma Corp
    18.7%$75.8MHistory
  2. ROIVRoivant Sciences Ltd.
    8.9%$36.1MHistory
  3. JOYYJOYY Inc.
    8.5%$34.6MHistory
  4. BALYBally's Corp
    8.1%$33.0MHistory
  5. GNWGenworth Financial Inc
    7.3%$29.6MHistory

Share of portfolio

Top 5 holdings and the other 14 positions, by share of portfolio value

  1. ABUS18.7%
  2. ROIV8.9%
  3. JOYY8.5%
  4. BALY8.1%
  5. GNW7.3%
  6. Other 14 positions48.4%

Biggest buys

New and added positions, by estimated amount bought

  1. NNNextnav Inc.
    +$27.4MAddedHistory
  2. ZDZiff Davis, Inc.
    +$21.9MNewHistory
  3. SOCSable Offshore Corp.
    +$6.70MAddedHistory
  4. DDIDoubleDown Interactive Co., Ltd.
    +$6.27MNewHistory
  5. PUBMPubMatic, Inc.
    +$5.52MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. NNNextnav Inc.
    +6.72 pp0.3% → 7.0%History
  2. ZDZiff Davis, Inc.
    +5.40 pp0.0% → 5.4%History
  3. PUBMPubMatic, Inc.
    +1.87 pp1.7% → 3.6%History
  4. DDIDoubleDown Interactive Co., Ltd.
    +1.55 pp0.0% → 1.5%History
  5. OPKOpko Health, Inc.
    +0.19 pp1.5% → 1.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ROIVRoivant Sciences Ltd.
    −$14.2MReducedHistory
  2. QUREuniQure N.V.
    −$10.8MSold outHistory
  3. OABIOmniAb, Inc.
    −$9.78MReducedHistory
  4. TDAYUSA TODAY Co., Inc.
    −$9.58MReducedHistory
  5. Nextnav Inc.65345N114
    −$299.2KSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. QUREuniQure N.V.
    −3.27 pp3.3% → 0.0%History
  2. ROIVRoivant Sciences Ltd.
    −3.07 pp12.0% → 8.9%History
  3. TDAYUSA TODAY Co., Inc.
    −2.48 pp6.7% → 4.2%History
  4. OABIOmniAb, Inc.
    −0.58 pp6.8% → 6.2%History
  5. Nextnav Inc.65345N114
    −0.09 pp0.1% → 0.0%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$405.7M
+$77.1M (+23.5%) vs. prior quarter
Positions
19
0 vs. prior quarter
Top 10 concentration
78.5%
Top 10 as share of value
Turnover
12.2%
Q2 2026, one quarter
Average holding period
8.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q4 2021), so positions held before then are understated.

13F filings by quarter

19 quarters, going back to Q4 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $405.7M (Q2 2026)

Q4 2021: $125.1MQ1 2022: $106.3MQ2 2022: $80.1MQ3 2022: $89.9MQ4 2022: $128.7MQ1 2023: $107.6MQ2 2023: $106.5MQ3 2023: $169.1MQ4 2023: $156.9MQ1 2024: $164.2MQ2 2024: $162.2MQ3 2024: $219.6MQ4 2024: $209.0MQ1 2025: $212.5MQ2 2025: $258.5MQ3 2025: $302.1MQ4 2025: $330.5MQ1 2026: $328.6MQ2 2026: $405.7M
Q4 2021Q2 2026
13F filings of Whitefort Capital Management, LP by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202619$405.7MABUSROIVJOYYvs. Q1 2026SEC
Q1 2026May 15, 202619$328.6MABUSROIVJOYYvs. Q4 2025SEC
Q4 2025Feb 17, 202617$330.5MABUSROIVBALYvs. Q3 2025SEC
Q3 2025Nov 14, 202516$302.1MABUSROIVGNWvs. Q2 2025SEC
Q2 2025Nov 12, 2025Amended17$258.5MJOYYROIVABUSvs. Q1 2025SEC
Q1 2025May 15, 202515$212.5MABUSROIVJOYYvs. Q4 2024SEC
Q4 2024Feb 14, 202518$209.0MABUSROIVLQDAvs. Q3 2024SEC
Q3 2024Nov 14, 202418$219.6MABUSEDRROIVvs. Q2 2024SEC
Q2 2024Aug 14, 202423$162.2MABUSROIVNNvs. Q1 2024SEC
Q1 2024May 15, 202419$164.2MGSLABUSROIVvs. Q4 2023SEC
Q4 2023Feb 14, 202421$156.9MGSLABUSROIVvs. Q3 2023SEC
Q3 2023Nov 14, 202318$169.1MChindata Group Hldgs LtdGSLABUSvs. Q2 2023SEC
Q2 2023Aug 14, 202315$106.5MGSLABUSGNWvs. Q1 2023SEC
Q1 2023May 12, 202316$107.6MGSLABUSGNWvs. Q4 2022SEC
Q4 2022Feb 14, 202321$128.7MGSLMYOVGNWvs. Q3 2022SEC
Q3 2022Nov 14, 202227$89.9MGSLLiberty Media Corp DelMTBLYvs. Q2 2022SEC
Q2 2022Aug 10, 202226$80.1MLiberty Media Corp DelMTBLYGSLvs. Q1 2022SEC
Q1 2022May 13, 202238$106.3MGSLMTBLYSRAXvs. Q4 2021SEC
Q4 2021Feb 14, 202240$125.1MAthene Holding Ltd.GSLMTBLY–SEC

13D and 13G filings

Companies where Whitefort Capital Management, LP reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

3 companies, largest stake first.

Companies where Whitefort Capital Management, LP owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
ABUSArbutus Biopharma Corp13G8.00%15.8M shares0.00 ppfrom 8.00%Sep 11, 20238 filingsSep 4, 2026SEC
VATEINNOVATE Corp.13G/A7.80%1.06M shares+0.20 ppfrom 7.60%Jan 24, 20252 filingsNov 14, 2025SEC
OABIOmniAb, Inc.13G/A7.10%10.2M shares−2.80 ppfrom 9.90%Jun 6, 20254 filingsAug 14, 2026SEC

Latest filings

24 filings on file made by Whitefort Capital Management, LP or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Whitefort Capital Management, LP
CompanyFiled (ET)FormStakeChangeEvent dateFiling
ABUSArbutus Biopharma CorpSep 4, 20266:32 PM ET13G8.00%15.8M shares0.00 ppfrom 8.00%Sep 4, 2026SEC
OABIOmniAb, Inc.Aug 14, 20264:48 PM ET13G/A7.10%10.2M shares−2.80 ppfrom 9.90%Jun 30, 2026SEC
ABUSArbutus Biopharma CorpApr 28, 20265:54 PM ET13D/A8.00%15.8M shares−0.10 ppfrom 8.10%Apr 24, 2026SEC
ABUSArbutus Biopharma CorpApr 13, 20267:56 PM ET13D/A8.10%15.8M shares+1.10 ppfrom 7.00%Apr 10, 2026SEC
BALYBally's CorpMar 12, 20265:02 PM ET13G/A4.90%2.41M shares−0.20 ppfrom 5.10%Below 5%Mar 12, 2026SEC
BALYBally's CorpMar 9, 20265:25 PM ET13G5.10%2.52M sharesNewMar 6, 2026SEC
OABIOmniAb, Inc.Nov 14, 20254:50 PM ET13G/A9.90%14.2M shares+1.50 ppfrom 8.40%Sep 30, 2025SEC
VATEINNOVATE Corp.Nov 14, 20254:12 PM ET13G/A7.80%1.06M shares+0.20 ppfrom 7.60%Sep 30, 2025SEC
OABIOmniAb, Inc.Aug 14, 20254:20 PM ET13G/A8.40%10.2M shares+2.40 ppfrom 6.00%Jun 30, 2025SEC
OABIOmniAb, Inc.Jun 6, 20256:42 PM ET13G6.00%7.31M sharesNewMay 30, 2025SEC
ABUSArbutus Biopharma CorpFeb 21, 20259:00 AM ET13D/A7.00%13.3M shares–Feb 20, 2025SEC
VATEINNOVATE Corp.Jan 24, 20254:40 PM ET13G7.60%1.03M sharesNewJan 21, 2025SEC
CDZICadiz IncDec 6, 202413G/AOld format–––SEC
GSLGlobal Ship Lease, Inc.Nov 14, 202413G/AOld format–––SEC
CDZICadiz IncNov 12, 202413GOld format–New–SEC
ABUSArbutus Biopharma CorpMay 17, 202413D/AOld format–––SEC
ABUSArbutus Biopharma CorpMay 9, 202413DOld format–––SEC
ABUSArbutus Biopharma CorpFeb 14, 202413G/AOld format–––SEC
CEECentral & Eastern Europe Fund, Inc.Feb 14, 202413G/AOld format–––SEC
GSLGlobal Ship Lease, Inc.Feb 14, 202413G/AOld format–––SEC